Dyasonic is here!

 

 

A Tubeless Triumph

Omnipod and Marvel joined forces to create a custom Marvel comic to celebrate representation for the diabetes community and empower people with diabetes to unleash their inner hero. Boom! Bam! Wham! You won't want to miss this original comic penned by a writer with diabetes.

Meet Omnya

Omnya is an ordinary high school student who loves science and technology and struggles to manage her type 1 diabetes. And, when she least expects it, D'Spayre creeps into every aspect of her life. With an Omnipod 5 on her arm, Omnya learns that when her glucose levels are in range, she can take on anything or anyone. Read about Omnya's epic transformation into Dyasonic in Dyasonic: Sound of Strength.

Omnipod's Marvel superhero, "Omnya," also known as, "Dyasonic". Omnipod's Marvel superhero, "Omnya," also known as, "Dyasonic".

Share to Benefit People with Diabetes

For every Instagram post that includes a Dyasonic GIPHY or Sticker, Omnipod will donate $1 to Children with Diabetes, up to $25,000, to help families attend future Friends for Life Orlando conferences. Don't forget to tag Children with Diabetes and Omnipod to make your post count!

Omnipod Marvel superhero, "Dyasonic," jumping through the air Omnipod Marvel superhero, "Dyasonic," jumping through the air
Omnipod Marvel superhero, "Dyasonic," charging up Omnipod Marvel superhero, "Dyasonic," charging up
Omnipod Marvel superhero, "Dyasonic," glowing from chest Omnipod Marvel superhero, "Dyasonic," glowing from chest

How to Use Dyasonic GIFs and Stickers:

Icon of a GIPHY

Open the GIPHY app or go to Instagram Stories or Reels, then search "Omnipod" to find Dyasonic GIFs and stickers.

Icon of Instagram Stories in orange

On Instagram, open your Story or Reel, tap the sticker icon, then choose GIF and search "Omnipod" to add it directly.

Icon of Instagram's Resize feature in orange color

Use two fingers to resize and position the sticker anywhere on your Story or Reel.

Icon of Instagram's tagging feature with "@" in orange

Tag @Omnipod and @CWDiabetes, then share your Story or Reel to spread the fun!

Children with Diabetes logo Children with Diabetes logo

The Friends for Life Orlando scholarship program helps make the conference an unforgettable experience for families managing type 1 diabetes and is designed for first-time attendees who might otherwise be unable to afford to attend. The scholarship covers registration for a family of four and provides a hotel stay at Disney's Coronado Springs Resort for the duration of the conference.

Children with Diabetes is a 501(c)3 dedicated to providing education and support to families living with type 1 diabetes.

childrenwithdiabetes.com

Be sure to follow and tag us on Instagram!

@CWDiabetes | @Omnipod

Comic book cover image of Marvel and Omnipod's superhero, "Dyasonic". Comic book cover image of Marvel and Omnipod's superhero, "Dyasonic".

Dyasonic: Sound of Strength.
A Must Read.

Can’t get your hands on a copy? Never fear, you can read it, share it and read it again with the Marvel E-Reader.

Omnipod POD no adhesive Omnipod POD no adhesive

Pod Power

Discover your power with Omnipod 5. It's tubeless, waterproof*, and delivers insulin for up to 3 days (72 hours).

*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Controller is not waterproof.

Risk Statement

The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older.

The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®.

The Omnipod 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices.

SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values

The Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on userentered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value

WARNING: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.

The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit www.omnipod.com/safety for additional important safety information.

WARNING: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.

INS-OHS-05-2025-00175 v1.0